PEG MGF Research Information
PEGylated Mechano Growth Factor
For Muscle Growth & Regenerative Research
️ Important: This information is for educational and research purposes only. Always consult with a qualified healthcare professional before use.
Contents
What is PEG MGF?
PEG MGF (PEGylated Mechano Growth Factor) is a synthetic 24-amino acid peptide derived from the insulin-like growth factor-1 (IGF-1) gene, modified with polyethylene glycol (PEG) to extend its half-life and biological activity. It is a splice variant of IGF-1 that is expressed in response to muscle damage and mechanical loading.
PEGylation increases the half-life of MGF, allowing for sustained biological activity and less frequent dosing. MGF plays a crucial role in muscle satellite cell activation and muscle repair. PEG MGF is available in pen and freeze-dried vial formulations for research purposes.
How PEG MGF Works
PEG MGF works through multiple mechanisms to support muscle growth and repair:
Satellite Cell Activation
Activates muscle satellite cells for muscle repair and growth
PEGylation
PEG modification extends half-life and increases bioavailability
Muscle Repair
Promotes muscle regeneration and recovery after exercise
PEG MGF is distinct from regular IGF-1 as it specifically targets muscle satellite cells and promotes muscle stem cell proliferation, rather than systemic growth effects.
Research Applications
Muscle Growth
Studying satellite cell activation and muscle hypertrophy
Tissue Repair
Investigating muscle regeneration and recovery mechanisms
Sarcopenia Research
Studying age-related muscle loss and therapeutic interventions
IGF-1 Splice Variant Research
Investigating MGF-specific signaling pathways
Clinical Studies
Satellite Cell Activation
- MGF specifically activates muscle satellite cells, promoting muscle repair
- Plays a crucial role in the early response to muscle damage
- PEGylation extends half-life for sustained biological activity
Muscle Repair & Regeneration
- MGF is expressed in response to mechanical loading and muscle injury
- Promotes myoblast proliferation and differentiation
- Distinct from systemic IGF-1 effects
Key Research Findings
- MGF is a splice variant of the IGF-1 gene
- Specifically targets muscle tissue for localized effects
- PEGylation improves pharmacokinetics and therapeutic potential
Interactive Dosing Guide
Select your vial size and dose to see the corresponding volume, clicks, dosing frequency, and how many doses per vial:
️ Step 1: Select Your Vial Size
Step 2: Select Your Dose
Common research protocols: 0.02-0.2 mg per injection, typically administered post-workout or before bedtime.
Vial Size
2mg Vial
Selected Dose
0.1 mg
Doses per Vial
20 doses
Pen Clicks
15 clicks
Volume
0.15 mL
Protocol Level
Level 2 (Standard)
Recommended Schedule
Post-workout - Research Protocol
️ Do not change your dose unless advised by a qualified professional.
Protocol Level Summary
Based on research protocols: 0.02-0.2 mg per injection, typically post-workout.
| Protocol Level | Target Dose | Frequency | Pen Clicks | Volume (mL) | Who It\'s For |
|---|---|---|---|---|---|
| Level 1 (Starting) | 0.02-0.05 mg | Post-workout | 3-7.5 clicks | 0.03-0.075 mL | New users, first 2 weeks |
| Level 2 (Standard) | 0.1 mg | Post-workout | 15 clicks | 0.15 mL | After 2 weeks, maintenance |
| Level 3 (Advanced) | 0.15 mg | Post-workout | 22.5 clicks | 0.225 mL | If more response needed |
| Level 4 (Maximum) | 0.2 mg | Post-workout | 30 clicks | 0.30 mL | Experienced users only |
️ Do not change your dose unless advised by a qualified professional.
Vial Users (Insulin Syringe)
Add 3mL of bacteriostatic water to your freeze-dried vial and mix gently. After reconstitution, use the table below to draw your dose:
Vial Size
2mg vial with 3mL bac water
| Dose | Frequency | Units on Syringe | Volume (mL) | Protocol Level |
|---|
️ Always use a new sterile needle and syringe for each injection.
️ Safety & Precautions
PEG MGF is generally well-tolerated at recommended doses. However, human safety data is limited as it is an investigational research peptide.
- Injection site reactions: Mild redness or tenderness at injection site
- Muscle soreness: Occasional and mild
- Headache or fatigue: Rare
Important Safety Considerations:
- PEG MGF is not FDA-approved for any indication
- Human data is very limited; most research is preclinical
- Do not use if allergic to PEG MGF or any ingredients
- Do not use if pregnant or breastfeeding
️ Warning: PEG MGF is an investigational peptide with limited human safety data. If you experience severe allergic reactions, difficulty breathing, or signs of anaphylaxis, seek immediate medical help.
References
- PEG MGF Research Overview. Peptide Sciences.
- PEG MGF Technical Guide. Benchchem.
- MGF: A Splice Variant of IGF-1. Journal of Peptide Research.
This information is for educational and research purposes only. Always consult with a qualified healthcare professional.
Last updated: July 2026